The Cancer Vaccine (INTISMERAN) Records Elevated Volume Relative to Market Cap on Solana

Risk Overview

The Cancer Vaccine (INTISMERAN) exhibits elevated risk due to a significant disparity between trading volume and liquidity. With a liquidity figure of $89,171, the market conditions present a concerning risk level.

INTISMERAN price chart, 72 candles to Aug 19, 2026 — Snapshot captured Aug 19, 2026 · View live chart →

Scalper risk score 61/100 Elevated

Elevated risk (61/100). The strongest contributor is volume vs liquidity: 24h volume is 103.2x the pool's liquidity. The same liquidity is being turned over repeatedly, which can indicate wash trading or bot activity. Assessed on 7 of 8 components; holder concentration unavailable.

Market readThe pool turns over 103.2 times a day — among the most actively traded relative to its depth, with continuous flow on both sides.

Volume vs liquidity: 103.2x
Pair maturity: 1.2 hours
Liquidity lock: 34.7% locked
Liquidity depth: $89,171

7 of 8 components assessed · partial confidence · GoPlus + RugCheck

Full risk assessment and coverage for INTISMERAN →

Liquidity Assessment

The liquidity stands at $89,171. Liquidity is 9.3% of market cap, close to the 9.1% typical at this size. $89,171 of liquidity is workable for small positions, but larger orders will move the price against you.

Volume Assessment

The 24-hour trading volume is reported at $9,203,360. The condition indicates that 24-hour volume is 103.2x the pool's liquidity. The same liquidity is being turned over repeatedly, which can indicate wash trading or bot activity.

Trading Behaviour

In the last hour, there were 35,150 buys and 33,018 sells, resulting in a buy/sell ratio of approximately 1.06. Transaction-level buy/sell data was not available.

Risk Note

This article does not constitute financial advice.